Nalidixic acid-susceptible, ciprofloxacin-resistant Neisseria gonorrhoeae strain in the UK.

1. Rao D, Rao JR, Crothers, E et al. Increased erythromycin resistance in clinical Campylobacter in Northern Ireland—an update. J Antimicrob Chemother 2005; 55: 395–6. 2. Bowler ICJW, Connor M, Lessing, MP et al. Quinolone resistance and Campylobacter species. J Antimicrob Chemother 1996; 38: 315. 3. Health Protection Agency. http://www.hpa.org.uk/infections/ topics_az/campy/data_ew.htm (15 February 2005, date last accessed). 4. The Campylobacter Sentinel Surveillance Scheme Collaborators. Ciprofloxacin resistance in Campylobacter jejuni: case–case analysis as a tool for elucidating risks at home and abroad. JAntimicrobChemother 2002; 50: 561–8. 5. Humphrey TJ, Jorgensen F, Frost JA et al. Prevalence and subtypes of ciprofloxacin-resistantCampylobacter spp. in commercial poultry flocks before, during, and after treatment with fluoroquinolones. Antimicrob Agents Chemother 2005; 49: 690–8. 6. Dingle KE, Colles FM, Wareing DR et al. Multilocus sequence typing system for Campylobacter jejuni. J Clin Microbiol 2001; 39: 14–23.